REFERENCIAS

1. Perros P. American Thyroid Association. 2009 American Thyroid Association guidelines on thyroid nodules. Clin Oncol (R Coll Radiol) 2010; 22(6): 469-471.

2. Mallick UK. American Thyroid Association. The revised American Thyroid Association management guidelines 2009 for patients with differentiated thyroid cancer: an evidence-based risk-adapted approach. Clin Oncol (R Coll Radiol) 2010; 22(6): 472-4.

3. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 2009; 19(12): 1363-1372.

4. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 1997; 82(2): 338-341.

5. Elisei R. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008; 22(6): 941-953.

6. Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid 2009; 19(12): 1373-1380.

7. Hartl DM, Travagli JP. The updated American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: a surgical perspective. Thyroid 2009; 19(11): 1149-1151.

8. Urken ML. The management of well differentiated thyroid cancer in 2010. Endocr Pract 2010; 16: 1-29.

9. Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg 2010; 34(6): 1239-46.

10. Shaha AR. Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 2009; 146(6): 1224-7.